An Open‐Label Split‐Body Clinical Trial Evaluating Therapeutic Efficacy and Safety of Cold Atmospheric Plasma in Canine Acute Otitis Externa

Key Points

• To evaluate the therapeutic efficacy and safety of cold atmospheric plasma in treating canine acute otitis externa.
• Conducted an open-label split-body clinical trial.
• Evaluated canine subjects diagnosed with acute otitis externa.
• Compared treatment outcomes with cold atmospheric plasma and standard care.
• Cold atmospheric plasma was found to be safe for canine use.
• Indicated potential efficacy as an adjunct therapy for acute otitis externa.